LegisTrack
Back to all bills
HRES 256119th CongressIn Committee

Supporting the designation of March 2025 as Endometriosis Awareness Month.

Introduced: Mar 26, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs

This House Resolution (H. Res. 256) introduces a symbolic, non-binding designation of March 2025 as Endometriosis Awareness Month. It is sponsored by Rep. David Scott (and co-sponsors) and referred to the Committee on Energy and Commerce. The resolution notes that endometriosis is a common gynecological disease that affects about 1 in 10 women of reproductive age, often with delayed diagnosis and substantial health, personal, and economic impacts. It expresses broad Congressional support for raising awareness, encouraging early detection and treatment, improving education for health care providers, and advancing research toward better treatments and, ultimately, a cure. The measure urges Americans to observe the month with awareness and educational activities. There is no new funding or mandate in the text; its effect is to publicly acknowledge and promote Endometriosis Awareness Month.

Key Points

  • 1Designation: The bill supports designating March 2025 as Endometriosis Awareness Month and encourages awareness and educational activities during that month.
  • 2Context and justification: It provides background on endometriosis, including prevalence (about 1 in 10 women of reproductive age), common diagnostic delays, and the substantial personal and economic costs associated with the disease.
  • 3Goals for awareness: Emphasizes early detection and treatment, increased education for health care providers, and more culturally competent care.
  • 4Research and treatment: Reaffirms a commitment to supporting and funding endometriosis research to develop more effective treatments, improve fertility outcomes, and pursue a cure.
  • 5Public engagement: Appeals to the public to observe the month with appropriate awareness and educational activities.

Impact Areas

Primary group/area affected: Women of reproductive age who have endometriosis, along with their families and caregivers; health care providers who diagnose and treat the condition; patient advocacy groups; and public health educators.Secondary group/area affected: Employers and workplaces (through potential improvements in productivity and reduced lost work time linked to better awareness and management); researchers and medical societies; policymakers and educational institutions.Additional impacts: The resolution is ceremonial and non-binding; it does not create new programs or authorize spending. Its value lies in raising public awareness, potentially influencing private funding and public discourse, and encouraging continued focus on research, diagnosis, and education related to endometriosis.
Generated by gpt-5-nano on Nov 1, 2025